Azvudine is a nucleoside analogue antiviral agent acting as a reverse transcriptase inhibitor, primarily developed for the treatment of hepatitis C and other viral infections. This category provides essential… Read more




Azvudine is a nucleoside analogue antiviral agent acting as a reverse transcriptase inhibitor, primarily developed for the treatment of hepatitis C and other viral infections. This category provides essential tools for pharmaceutical research, including high-quality reference standards for the Azvudine API, as well as a comprehensive range of non-pharmacopeial impurities and metabolites. Analytical laboratories rely on these compounds to perform rigorous impurity profiling and ensure the accuracy of identification techniques during quality control procedures. Additionally, the inclusion of stable isotope labelled compounds facilitates reliable quantification in complex matrices, supporting robust method development and validation. These materials are critical for verifying the purity and stability of drug formulations, helping to ensure regulatory compliance throughout the lifecycle of pharmaceutical development.